Chemotherapy News and Research

Latest Chemotherapy News and Research

18F-DG PET/CT can highly increase the detection of colorectal cancer

Combined positron emission tomography and computed tomography (PET/CT) is currently widely used in the clinical diagnosis of cancer to provide functional and morphological imaging.

10 Oct 2007

Women on low-fat diets reduce their risk of ovarian cancer

The American Cancer Society, estimates that as many as 22,400 women in the United States will be diagnosed with ovarian cancer this year and of that number around 15,200 will die from the disease.

10 Oct 2007

Complementary medicine for chronic pain

Mr. Jones has chronic back pain. He cannot sleep, bend or stand for long periods of time because of the pain. He cannot lose weight because the pain keeps him from exercising.

10 Oct 2007

Decrease in the use of radiotherapy procedures for the treatment of cancer in hospitals

The Department of Radiology and Physical Medicine of the Universidad de Granada, in Andalusian hospitals radiotherapy is not used as much as should be expected for the treatment of cancer, in favour of other procedures such as chemotherapy or surgery.

10 Oct 2007

African-American women less likely to have adjuvant cancer therapy than white women

A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.

9 Oct 2007

Xeloda (capecitabine) better all round for cancer patients

A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects - and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.

9 Oct 2007

Treatment for breast cancer differs between African-American women and white women

The study found that, among patients with breast cancer that had spread to the lymph nodes, African-Americans were less likely to have adjuvant cancer therapy than white women. In this clinical group, white women were almost five times more likely to take Tamoxifen, a widely-used cancer therapy medication, and over three times more likely to have chemotherapy.

9 Oct 2007

Completion of first clinical trial of Apatone for cancer treatment

In a significant advancement in the ongoing battle against cancer, a group of researchers from Summa Health System, IC-MedTech and other institutions have completed the first ever FDA-approved human clinical trial of Apatone®.

8 Oct 2007

Researchers create modular, multi-functional drug delivery system

There are two aspects to creating an effective drug: finding a chemical compound that has the desired biological effect and minimal side-effects and then delivering it to the right place in the body for it to do its job.

8 Oct 2007

Thalidomide therapy helps elderly myeloma patients live longer

The drug thalidomide is making a comeback as a cancer fighting therapy and has been successfully used along with standard therapy to treat the blood cancer myeloma.

7 Oct 2007

How Candida albicans transforms from its normally benign form into life-threatening form

Researchers at the Agency for Science, Technology and Research's (A*STAR) Institute of Molecular and Cell Biology (IMCB) have discovered new molecular mechanisms that provide a more detailed understanding of how the normally benign Dr. Jekyll-like fungus known as Candida albicans transforms into a serious and often life-threatening Mr. Hyde-like form.

4 Oct 2007

Cell's cytoskeleton may hold key to overcoming drug resistance in cancer

Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.

4 Oct 2007

Individually tailored herbal concoctions possibly harmful

Scientists in Britain are warning that there is no evidence to suggest herbal medicines "tailored" to the individual do actually work; they also say such concoctions may even be harmful.

4 Oct 2007

Re-educating immune system cells slows tumour growth

Immune system cells recruited by cancers to help them grow and spread could be 're-educated' to attack the tumours instead of aiding them, Cancer Research UK scientists announced at the National Cancer Research Institute (NCRI) Conference in Birmingham today (Wednesday).

4 Oct 2007

Cancer trial combines multiple drugs to attack blood vessel formation in patients with kidney cancer

In the first clinical trial of its kind, researchers at the University of Pennsylvania School of Medicine and the Abramson Cancer Center will lead a nationwide test of anti-cancer drug combinations that target blood vessel growth in patients with advanced kidney cancer.

4 Oct 2007

Missouri-Columbia researchers look at mechanisms of cisplatin drug sensitivity

Resistance to chemotherapy treatments can be the worst news a cancer patient ever receives. A pair of researchers at the University of Missouri-Columbia is working steadfastly to learn why some tumors eventually build a tolerance to the common chemotherapy drug cisplatin, in hopes of identifying the particular genes that can be manipulated to make treatment as effective as possible.

3 Oct 2007

Cognitive deficits lead to 'loss of self' among cancer patients

For some cancer patients, side effects impacting cognition don't end with the last dose of chemotherapy. According to a new survey, the cognitive impairment experienced by 14 to 45 percent of cancer patients can be long-lasting and severely affect their personal and professional lives.

3 Oct 2007

Early stage drug shows promise against cancer cells from young patients

A new drug has shown promising pre-clinical activity against cells from several types of children's cancers, scientists reveal at the National Cancer Research Institute Conference in Birmingham today (Tuesday).

2 Oct 2007

Breast health and cancer prevention tips for women and men

In addition to the bright reds, oranges and yellows seen as the leaves turn this fall, pink will be everywhere during October, which is National Breast Cancer Awareness Month.

2 Oct 2007

Daisy compound used to attack cancer stem cells

A new, easily ingested form of a compound that has already shown it can attack the roots of leukemia in laboratory studies is moving into human clinical trials, according to a new article by University of Rochester investigators in the journal, Blood.

2 Oct 2007